Vp Shunt For Brain Tumor

A ventriculoperitoneal shunt is a medical device that doctors use to treat a brain condition called hydrocephalus.

Vp shunt for brain tumor. A ventriculoperitoneal vp shunt is a medical device that relieves pressure on the brain caused by fluid accumulation. 4 hydrocephalus is typically managed surgically with short term options including extraventricular or lumbar drainage usually as a bridge to more permanent solutions such as endoscopic third ventriculostomy or ventriculoperitoneal vp shunt placement. Hydrocephalus involves a build up of excess fluid within the brain as a result of an obstruction in the brain that prevents proper fluid drainage.

To help drain the extra csf from your brain a vp shunt will be placed into your head. Reported risk factors for the development of ch include surgical entrance into the ventricular system 3 and leptomeningeal tumor spread. A shunt procedure is a type of brain tumor surgery that can help alleviate pressure within the skull.

Shunt infection was encountered in 24 5 of cases. This lowers the pressure and swelling in your brain. One end of the shunt is placed in a ventricle of the brain an area filled with csf and the other end is placed in the abdomen or less often the heart and would then be referred to as a ventriculoatrial shunt.

Vp shunting is a surgical procedure that primarily treats a condition called. In a healthy individual a clear watery liquid called cerebral spinal fluid csf circulates throughout the brain and spine serving as a cushion that protects against damage. This condition is usually present at birth although it can develop later in life as a result of lesions or tumors within the brain central nervous.

For example the neurosurgeon may put in a silicone tube called a shunt sometimes referred to as a ventriculoperitoneal or vp shunt. The tube runs under the skin of the neck and chest. Hydrocephalus is a condition that causes fluid to build up on the brain which.

Some case series have explored the benefit of vp shunting in patients with glioblastoma.